A Case of Sclerosing Panniculitis treated with Stanozolol.
- Author:
Jun Ha PARK
1
;
Kyu Chul HWANG
;
Jae Hong PARK
;
Soo Nam KIM
;
Young Chul KYE
Author Information
1. Department of Dermatology, College of Medicine, Korea University, Seoul, Korea. kumo2vi@medimail.co.kr
- Publication Type:Case Report
- Keywords:
Sclerosing panniculitis;
Indurated cellulitis;
Lipodermatosclerosis;
Stanozolol
- From:Korean Journal of Dermatology
2004;42(7):893-896
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Sclerosing panniculitis refers to indurated erythema with hyperpigmented scleroderma-like hardening on the medial lower third of the legs. It has been called indurated cellulitis, chronic cellulitis, hypodermitis sclerodermiformis or lipodermatosclerosis. It has been suggested that sclerosing panniculitis is associated with venous insufficiency. The treatment of sclerosing panniculitis is very difficult. Stanozolol is valuable in treating intractable sclerosing panniculitis, giving relief of pain, reducing induration, inflammation, tenderness and pigmentation by its fibrinolytic activity. We report a case of sclerosing panniculitis, clinically improved by stanozolol.
